share_log

Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity

Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity

聚焦禮來公司:分析期權交易的激增
Benzinga ·  06/17 21:47

Deep-pocketed investors have adopted a bullish approach towards Eli Lilly and Co (NYSE:LLY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LLY usually suggests something big is about to happen.

富有的投資者對Eli Lilly and Co (NYSE:LLY)採取了看好的策略,市場參與者不應該忽視。我們在Benzinga跟蹤公開期權記錄時發現了這一重要舉動。這些投資者的身份尚不得知,但LLY如此大規模的舉動通常意味着即將發生重大事件。

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Eli Lilly and Co. This level of activity is out of the ordinary.

我們從Benzinga的期權掃描器今天突出顯示10個Eli Lilly and Co.的非同尋常期權活動中獲得了這些信息。這個級別的活動是非常不尋常的。

The general mood among these heavyweight investors is divided, with 50% leaning bullish and 10% bearish. Among these notable options, 2 are puts, totaling $99,275, and 8 are calls, amounting to $327,058.

這些重量級投資者的一般心態存在分歧,50%持看好態度,10%持看淡態度。在這些值得注意的期權中,2個是看跌期權,總額爲99,275美元,8個是看漲期權,總額爲327,058美元。

Projected Price Targets

預計價格目標

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $430.0 and $1000.0 for Eli Lilly and Co, spanning the last three months.

在評估成交量和持倉量後,明確的是,主要市場行動者正聚焦於Eli Lilly and Co的價格區間,跨越過去三個月的$430.0到$1000.0之間。

Insights into Volume & Open Interest

成交量和持倉量分析

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale trades within a strike price range from $430.0 to $1000.0 in the last 30 days.

當交易期權時,查看成交量和持倉量是一個強大的舉措。這些數據可以幫助您跟蹤Eli Lilly and Co某一行權價的期權的流動性和興趣。下面,我們可以觀察到Eli Lilly and Co的全部空頭交易和多頭交易的看漲期權和看跌期權的成交量和持倉量的演變,該行權價範圍爲$430.0到$1000.0,在過去30天內。

Eli Lilly and Co 30-Day Option Volume & Interest Snapshot

禮來30天期權成交量和持倉量快照

Options Call Chart

Biggest Options Spotted:

最大的期權交易:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
LLY PUT TRADE BULLISH 12/18/26 $80.0 $73.2 $73.2 $750.00 $73.2K 59 0
LLY CALL TRADE BEARISH 06/21/24 $133.5 $130.6 $130.6 $750.00 $65.3K 874 0
LLY CALL TRADE BULLISH 09/20/24 $60.0 $59.3 $60.0 $870.00 $60.0K 317 0
LLY CALL TRADE BULLISH 01/17/25 $467.95 $460.65 $465.0 $430.00 $46.5K 602 0
LLY CALL TRADE BULLISH 08/16/24 $129.6 $123.2 $127.82 $770.00 $38.3K 200 3
標的 看跌/看漲 交易類型 情緒 到期日 賣盤 買盤 價格 執行價格 總交易價格 未平倉合約數量 成交量
LLY 看跌 交易 看好 12/18/26 $80.0 $73.2 $73.2 $750.00 $73.2K 59 0
LLY 看漲 交易 看淡 06/21/24 $133.5 $130.6 $130.6 $750.00 $65.3K 874 0
LLY 看漲 交易 看好 09/20/24 $60.0 $59.3 $60.0 $870.00 $60.0K 317 0
LLY 看漲 交易 看好 01/17/25 $467.95 $460.65 $465.0 $430.00 $46.5K 602 0
LLY 看漲 交易 看好 08/16/24 $129.6 $123.2 $127.82 $770.00 $38.3K 200 3

About Eli Lilly and Co

關於禮來

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的維津尼奧;馬天尼羅、澤普邦、賈達信、特魯利康、胰島素諾和人用胰島素用於糖尿病;以及用於免疫學的塔吉特和優泰樂。

Following our analysis of the options activities associated with Eli Lilly and Co, we pivot to a closer look at the company's own performance.

在分析了禮來期權交易活動之後,我們轉而更近距離地觀察公司自身的業績。

Eli Lilly and Co's Current Market Status

禮來當前的市場狀態幣

  • Currently trading with a volume of 65,069, the LLY's price is down by -0.18%, now at $876.87.
  • RSI readings suggest the stock is currently may be overbought.
  • Anticipated earnings release is in 50 days.
  • 成交量爲65,069,LLY的股價下跌了-0.18%,目前爲876.87美元。
  • RSI讀數表明股票目前可能超買。
  • 預計收益報告將在50天內發佈。

Professional Analyst Ratings for Eli Lilly and Co

禮來的專業分析師評級

A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $909.0.

過去30天中,共有3位專業分析師對該股票發表了評論,平均目標價爲909.0美元。

  • An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
  • Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Eli Lilly and Co with a target price of $957.
  • An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
  • Cantor Fitzgerald的一位分析師將其評級下調爲超配,目標價爲885美元。
  • Jefferies的一位分析師在其評估中持續認爲禮來買入,目標價爲957美元。
  • Cantor Fitzgerald的一位分析師已經將其評級下調爲超配,將目標價調整爲885美元。

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly and Co options trades with real-time alerts from Benzinga Pro.

期權交易帶來更高的風險和潛在回報。精明的交易者通過持續教育自己、調整策略、監控多個因子、密切關注市場動態來管理這些風險。通過Benzinga Pro全天實時提醒了解最新的禮來期權交易。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論